Characterization of immunoreactive dynorphin in human phaeochromocytomas

Area of Science:

• Endocrinology
• Neuroscience
• Biochemistry

Background:

• Prodynorphin (PRODYN) is a precursor to various opioid peptides, including dynorphin (DYN) and alpha-neoendorphin (alpha NE).
• Phaeochromocytomas are neuroendocrine tumors arising from chromaffin cells, which can produce and secrete various peptides.

Purpose of the Study:

• To investigate the presence and characteristics of prodynorphin-derived opioids, specifically dynorphin (DYN) and alpha-neoendorphin (alpha NE), in human phaeochromocytomas.
• To determine if these tumors process prodynorphin into known opioid end-products.

Main Methods:

• Extraction of 24 human phaeochromocytomas and related tumors using hydrochloric acid (HCl) or acetic acid.
• Quantification of immunoreactive dynorphin (ir-DYN) and alpha-neoendorphin (ir-alpha NE) using radioimmunoassay.
• Characterization of ir-DYN by Sephadex G-50 gel filtration chromatography and high-pressure liquid chromatography (HPLC).

Main Results:

• Nineteen tumors contained significant levels of ir-DYN (up to 794 pmol/g), while ir-alpha NE was undetectable.
• Gel filtration and HPLC revealed multiple ir-DYN forms, with some eluting similarly to DYN(1-32) but none matching DYN(1-17).
• Extraction in acetic acid showed degradation of synthetic DYN and altered ir-DYN profiles, indicating lability of these peptides.

Conclusions:

• Phaeochromocytomas express prodynorphin but do not appear to process it into the typical end-products like DYN and alpha NE.
• The observed ir-DYN forms suggest unusual post-translational modifications or processing pathways in these tumors.
• Acetic acid extraction can lead to enzymatic degradation of DYN and should be avoided for labile peptide studies.